Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"140 - Specific philosophical schools"
dewey-ones:"330 - Economics"
dewey-ones:"700 - The arts; fine & decorative arts"
product_txtF_mv:"National Center for Biotechnology Information"
Showing
1
-
10
of
10
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
SBIR/STTR at the National Institutes of Health
Published 2015
The National Academies Press
Call Number:
HD2346.U6
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Read Now
3
Venture funding and the NIH SBIR program
by
Wessner, Charles W.
Published 2009
National Academies Press
Call Number:
HD2346.U6
Read Now
4
An assessment of the SBIR program at the National Institutes of Health
by
Wessner, Charles W.
Published 2009
National Academies Press
Call Number:
HD2346.U5
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Read Now
6
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
7
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
8
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
9
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
10
Pharmacoeconomic review report: Sarilumab (Kevzara)
Published 2017
CADTH
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Classification: 330 - Economics
Clear Filter
Classification: 700 - The arts; fine & decorative arts
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
330 - Economics
700 - The arts; fine & decorative arts
610 - Medicine & health
5
600 - Technology
2
338 - Production
1
more ...
658 - General management
1
see all ...
less ...
Language
English
10
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
7
CADTH Canadian Drug Expert Committee
2
National Research Council (U.S.) Committee on Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program
2
Wessner, Charles W.
2
National Academies of Sciences, Engineering, and Medicine (U.S.) Committee on Capitalizing on Science, Technology, and Innovation: An Assessment of the Small Business Innovation Research Program--Phase II
1
National Research Council (U.S.) Board on Science, Technology, and Economic Policy
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=dewey-ones%3A%22700+-+The+arts%3B+fine+%26+decorative+arts%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&type=AllFields
Send by Email
×
Loading...